To better understand how α-solanine exerts its therapeutic effects through the hub target STAT1 and improves the prognosis of glioma patients, we conducted a GSEA analysis to identify potential biological signalling pathways affected by the overexpression of STAT1 in glioma. The gene discussed is STAT1; the disease is central nervous system cancer.